SSR149744c
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SSR149744c, covering 2012-05-08 to 2012-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter [Phase 2, Phase 3]